The aim of the North Africa Regulatory Conference is to bring together key stakeholders and to discuss ways of improving access to medicines and therapies for the citizens and patients in the Region.
The Region is moving ahead rapidly in playing a major role in innovation and development of new medicines. A local as well as global perspective will support all key stakeholders in exchanging the current state of the art, best practices and future requirements as well as focus on getting guidelines into practice and practice into guidelines.
This regulatory conference will serve as an international and neutral forum for attendees to discuss how the different countries can play a leadership role in drug development. Speakers from local and international regulatory agencies, industry, and academia will present and will lead the panels and sessions.
The conference offers the opportunity for key stakeholders, including representatives from health authorities, local and multinational pharmaceutical companies, academia, and international governmental and non- governmental organisations to exchange progressive views on key topics of interest and identify focus areas for ongoing efforts aimed to increase patient access to new and improved medicines.
- Regulatory System Strengthening
- Good Regulatory Practices in the North Africa Region and Beyond
- Biotherapeutic Products and Biosimilars
- Medical Devices and in-vitro diagnostics
- OTCs Status
- Safety and Pharmacovigilance
- Sub-standards and Falsified Medicines
- Innovative Approaches in Medicine Developments
Who should attend?
The conference is directed at key stakeholders that are active or interested in this diverse and changing region, including representatives from regulatory agencies, ministries of health, local and multi-national pharmaceutical companies. You will have the opportunity to meet and exchange views, discuss topics of interest and identify actions to increase patient access to new and improved medicines and therapies:
- Representatives from health authorities
- Professionals in:
- Regulatory affairs
- Quality assurance
- Research & Development
- Other professionals involved in or interested in the aspects surrounding:
- Registration and life cycle management of medicinal products
- Regulatory convergence
Hala Kanaan Abu-Ghazalah • Regulatory Affairs Director
Pfizer Nutrition FZ LLC, United Arab Emirates
Sarah Adam • Head of Regulatory Science Policy – Africa
Samvel Azatyan, MD, PhD • Group Lead, Regulatory Networks and Harmonization (RNH/RSS)
World Health Organization (WHO), Switzerland
Samia Beddek • Head of Regulatory Affairs/ Qualified Person
Sanaa Cherradi • Regulatory Affairs Head MTL
Novartis Pharma Maroc, Morocco
Nevena Miletic • Regulatory Policy Lead – EEMEA & Chair of IFPMA CPP Network
F.Hoffmann-La Roche ltd, Switzerland
Smail Nahmed • Regulatory Affairs Manager North and West Africa
Jasmin Badcock • Associate Director, EMEA Emerging Markets Regulatory Liaison
Johnson & Johnson, United Kingdom
Kawaldip Sehmi • CEO
International Alliance Of Patients' Organizations (IAPO), United Kingdom
Myriam Sedrati • Regulatory Affairs Director North and West Africa
Merck Sharp & Dohme, Morocco
Yacine Sellam, PharmD, PhD • President
Algerian Society for Regulatory Affairs & Pharmacoeconomics (SAARPE), Algeria